231 related articles for article (PubMed ID: 20445224)
1. Cdk2: a key regulator of the senescence control function of Myc.
Hydbring P; Larsson LG
Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
3. Myc, Cdk2 and cellular senescence: Old players, new game.
Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
[TBL] [Abstract][Full Text] [Related]
4. Tipping the balance: Cdk2 enables Myc to suppress senescence.
Hydbring P; Larsson LG
Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
[TBL] [Abstract][Full Text] [Related]
5. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
[TBL] [Abstract][Full Text] [Related]
7. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
8. Myc and a Cdk2 senescence switch.
van Riggelen J; Felsher DW
Nat Cell Biol; 2010 Jan; 12(1):7-9. PubMed ID: 20027199
[TBL] [Abstract][Full Text] [Related]
9. Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Junk DJ; Cipriano R; Stampfer M; Jackson MW
PLoS One; 2013; 8(2):e53776. PubMed ID: 23390492
[TBL] [Abstract][Full Text] [Related]
10. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
11. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
12. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
13. c-Myc and activated Ras during skin tumorigenesis: cooperation at the cancer stem cell level?
Trumpp A
Ernst Schering Found Symp Proc; 2006; (5):13-26. PubMed ID: 17939293
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis.
Braun K; Hölzl G; Pusch O; Hengstschläger M
DNA Cell Biol; 1998 Sep; 17(9):789-98. PubMed ID: 9778038
[TBL] [Abstract][Full Text] [Related]
15. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Carbone CJ; Graña X; Reddy EP; Haines DS
Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4.
Haas K; Johannes C; Geisen C; Schmidt T; Karsunky H; Blass-Kampmann S; Obe G; Möröy T
Oncogene; 1997 Nov; 15(21):2615-23. PubMed ID: 9399649
[TBL] [Abstract][Full Text] [Related]
17. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence.
Hong L; Lai M; Chen M; Xie C; Liao R; Kang YJ; Xiao C; Hu WY; Han J; Sun P
Cancer Res; 2010 Nov; 70(21):8547-57. PubMed ID: 20851997
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 promotes premature senescence induced by oncogenic Ras.
Tombor B; Rundell K; Oltvai ZN
Biochem Biophys Res Commun; 2003 Apr; 303(3):800-7. PubMed ID: 12670482
[TBL] [Abstract][Full Text] [Related]
20. Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses.
Kelekar A; Cole MD
Mol Cell Biol; 1987 Nov; 7(11):3899-907. PubMed ID: 2963209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
